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Julio J. González-López, Francisco J. Muñoz-Negrete ⇑AbstractOptical coherence tomography (OCT) has become essential to evaluate axonal/neuronal integrity, to assess disease progression in
the afferent visual pathway and to predict visual recovery after surgery in compressive optic neuropathies. Besides that OCT
testing is considered a powerful biomarker of neurodegeneration and a promising outcome measure for neuroprotective trials
in multiple sclerosis (MS).
Currently, spectral-domain OCT (SD-OCT) technology allows quantification of retinal individual layers. The Ganglion Cell layer
(GCL) investigation has become one of the most useful tools from a neuro-ophthalmic perspective. It has a high correlation with
perimetry, is predictive of future progression and is a highly sensitive, specific of several neuro-ophthalmic pathologies. Moreover
the superior correlation with clinical measures compared to peripapillary retinal nerve fiber layer (pRNFL) suggests that GCL
analysis might be a better approach to examine MS neurodegeneration.
In disorders with optic disk edema, such as ischemic optic neuropathy, papillitis and papilledema, reduction in RNFL thickness
caused by axonal atrophy is difficult to distinguish from a swelling resolution. In this setting, and in buried optic nerve head drusen
(ONHD), GCL analysis may provide more accurate information than RNFL analysis and it might be an early structural indicator of
irreversible neuronal loss.
Enhanced depth imaging OCT (EDI-OCT) provides in vivo detail of ONHD, allowing to evaluate and quantify the drusen
dimensions.
OCT is improving our knowledge in hereditary optic neuropathies. Furthermore, there is growing evidence about the role of OCT
as an adjunctive biomarker of disorders such as Alzheimer and Parkinson’s disease.
Keywords: Neuro-ophthalmology, Optical coherence tomography, Ganglion cell layer
 2014 Production and hosting by Elsevier B.V. on behalf of Saudi Ophthalmological Society, King Saud University.
http://dx.doi.org/10.1016/j.sjopt.2014.09.016Introduction
Optical coherence tomography (OCT) has revolutionized
ophthalmology and it has become one of the most important
tools in neuro-ophthalmic practice.
Time-domain OCT (TD-OCT) was widely used in clinical
practice and currently replaced by the newer Spectral-
Domain OCT (SD-OCT) technology that offers considerableimprovements. SD-OCT has faster acquisition time and
higher resolution than TD-OCT, providing high quality three
dimensional images. Furthermore it can track eye movements
and it has eliminated operator bias with automatic centering.
OCT is a quick, sensitive, non-invasive, user-friendly device
that provides high-resolution images of the peripapillary ret-
inal nerve fiber layer (pRNFL), macular volume, macular gan-
glion cell layer (GCL), and optic nerve head, yieldinge:
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10 G. Rebolleda et al.reproducible and reliable measurements. OCT allows us to
search about axonal-neuronal integrity in the afferent visual
pathway and, compared with perimetry, is faster, more
reproducible, precise and less dependent on patient.
Depending on the type of disorder, OCT provides data
relevant for diagnosis, follow-up, and prognosis. Although
diagnosis exclusively based on OCT is not possible, in some
diseases there are pathognomonic findings leading to cor-
rect diagnosis. This review gives an overview on current
applications, typical changes, new perspectives and future
directions of the OCT in the following diseases: optic neuritis
(isolated or associated with multiple sclerosis or neuromyeli-
tis optica), anterior ischemic optic neuropathy, papilledema,
optic nerve head drusen, autosomal dominant optic atrophy,
Leber hereditary optic neuropathy and neurodegenerative
diseases.Optic neuritis/multiple sclerosis
Multiple sclerosis (MS) is a disorder characterized by
inflammation and neuro-axonal degeneration. Optic neuritis
(ON) is one of the manifestations of MS and is the presenting
event in 25–50% of MS cases. Given its high degree of reli-
ability, sensitivity and ease of use, OCT is an ideal method
for assessing pathologic changes in the anterior visual path-
way of patients with ON and MS.Retinal nerve fiber layer thickness
Firstly reported by Parisi in 1999, thinning of pRNFL by
OCT, is a well-documented structural marker of axonal
degeneration in MS, which occurs even in the absence of
optic neuritis (ON).1–6
OCT confirms the presence of optic disk edema in
anterior ON, and quantifies the severity of axonal loss that
follows the acute episode. OCT can detect subclinical
axonal loss in eyes with normal visual fields and normal
visual acuity (Figs. 1 and 3).7
Meta-analyses of data for TD-OCT show that RNFL
thinning is milder in MS without ON (7.08 lm) than in eyes
that have suffered ON (20.38 lm) and it is more pronounced
in the temporal quadrant.4
Rebolleda et al. demonstrated by OCT an enlarged cup to
disk ratio after unilateral ON that correlated with RNFL thin-
ning (Fig. 2). A cupping asymmetry equal or greater than 0.2
was present in around 25% of cases.8
RNFL thickness correlates with visual and neurological
functioning as well as with paraclinical data and disease dura-
tion. The strongest correlations were shown in studies includ-
ing patients with MS and ON antecedent.3,4,9
A moderate association has also been shown between the
RNFL thickness and several magnetic resonance imaging
(MRI) findings characteristic of brain atrophy.3,10 A strong cor-
relation with MRI results is unlikely since axons are not the only
component of the brain and brain atrophy also reflects loss of
myelin, gliosis, synaptic and water content changes.
Studies using newer SD-OCT corroborate previous
findings by TD-OCT, where RNFL thinning typically occurs in
the temporal quadrant,5,11–13 although measurement
values cannot be directly compared and there is also a
substantial color-code disagreement among SD-OCT devices
(Fig. 1).13,14Spectralis-OCT incorporated the N-site axonal protocol
which differs from the standard pRNFL scan because it starts
and terminates in the nasal side of the optic nerve, focusing
on the temporal quadrant. Using this protocol in patients
with remitting-relapsing MS (RRMS), Spectralis yields a signif-
icantly higher thinning for the temporal quadrant than OCT
Cirrus in non-ON eyes, suggesting that N-site axonal analysis
could define axonal damage earlier than conventional RNFL
analysis.5Macular and Ganglion cell layer thickness
Initially, OCT focused primarily on the evaluation of
pRNFL. The latest OCT investigations involve segmentation
of specific retinal layers allowing quantification of both axo-
nal damage (RNFL) and neuronal degeneration. Several stud-
ies have shown that patients with RRMS exhibit a significant
thinning of both, pRNFL and ganglion cell layer (GCL),15–19
and the damage is more pronounced in eyes with ON ante-
cedent (Fig. 1).
OCT-GCL thickness analysis is more sensitive to detect
damage and is reduced before than pRNFL analysis in RRMS
patients, even in the absence of a previous episode of
ON.18,19 Unsurprisingly, the sectors showing the highest
abnormality rate in GCL analysis are the supero and infero-
nasal (Fig. 3).20 Moreover, macular GCL thickness correlates
better with visual dysfunction [visual acuity (VA), low-contrast
letter acuity, and vision-specific quality of life measures,
visual field mean deviation (MD)], disability and MRI than
RNFL thickness.15,18
The improved reproducibility of SD-OCT enhances the
value of the analyzed data from individual quadrants in the
longitudinal evaluation of MS patients.21,22 Progressive RNFL
and ganglion cell inner plexiform layer (GCIPL) thinning
occurs as a function of time in patients with MS, even in the
absence of ON, and is associated with clinically significant
visual loss.23–27 Narayanan reported that RNFL and GCIPL
decreased with follow-up time by 1.49 and 0.53 lm/year,
respectively.25 Progressive changes seem to correlate with
changes in neurological impairment measured by the
Expanded Disability Status Scale (EDSS).Macular edema and MS
SD-OCT has become the most useful tool for the diagno-
sis of macular edema that could appear in MS patients with
intermediate uveitis or as a side effect of Fingolimod (FTY-
720). A review of clinical trials reported that Fingolimod
0.5 mg and 1.25 mg were associated with a low incidence
of macular edema (0.3% and 1.2%, respectively) that is a
dose-dependent adverse event and typically resolves upon
cessation of therapy. An ophthalmic examination before initi-
ating fingolimod therapy and regular follow-up eye examina-
tions by OCT during therapy are recommended.28
In 2012, Gelfand et al.29 identified by OCT a microcystic
macular edema (MME) in patients with demyelinating optic
neuropathy. MME is characterized by small hyporeflective
spaces within the inner nuclear layer (INL) in the parafoveal
region of the retina. In microvacuolar aspect, the sparing of
fovea and the limitation to the INL distinguish MME from
other macular edemas caused by vascular leakage (Fig. 4).
Figure 1. A 32 year-old woman diagnosed of remitting-relapsing multiple sclerosis (RRMS) with ON antecedent just in the left eye having bilateral RNFL
thinning by Spectralis (A) and Cirrus-OCT(B) although more accentuated in the involved left eye. Damage predominates in the temporal quadrant in both
eyes. Despite RNFL thinning, visual acuity is 20/20 in both eyes and visual fields remain normal (C).
Figure 2. Acquired optic disk cupping after an optic neuritis episode in the right eye. Temporal RNFL loss is shown in fundus photograph (black arrows).
RNFL thinning predominates in the temporal quadrant (OCT-Cirrus).
Figure 3. Axonal and neuronal damage at 6 months after a left anterior optic neuritis. Temporal optic disk pallor (A), temporal RNFL thinning (B) and the
corresponding supero-nasal CGL thinning (C). Visual field is normal (D).
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Figure 4. Patient with RRMS, showing in the left eye a microcystic macular edema located in the inner nuclear layer, nasal and temporally. There is a
significant thinning of both RNFL and GCIPL thickness (image provided by Santos-Bueso E).
12 G. Rebolleda et al.MME and thickening of the INL on OCT were associated
with disease activity and worse disability in MS, leading to
consider as useful predictor of disease progression in
patients with MS.30 However, this finding is not specific for
demyelinating disease and can be found in numerous disor-
ders such as compressive, nutritional/toxic, and hereditary
optic neuropathies. Nowadays, MME is considered a sign
of optic neuropathy irrespective of its etiology and the dis-
tinctive intraretinal anatomy suggests that it is caused by ret-
rograde degeneration of the inner retinal layers, resulting in
impaired fluid resorption in the macula.31
MS subtypes and neuromyelitis optica
OCT measurements differ among MS subtypes.32 RNFL
thinning in the secondary progressive MS (SPMS) forms is
more pronounced than in patients with RRMS, and total mac-
ular volumes are lower in SPMS than in primary progressive
MS (PPMS). Saidha et al. reported thinning of the GCIPL in
all MS subtypes but it was most prominent in SPMS.18
Several reports have reported that visual prognosis is
much worse and axonal loss is greater after an episode of
ON in patients with neuromyelitis optica (NMO) than in
patients with MS, even after adjusting the RNFL for visual
outcome. It has also been shown that the superior and infe-
rior quadrants are more intensely affected after NMO.33–36
Moreover, patients with NMO and longitudinally extensive
transverse myelitis (LETM) had a significantly thicker INL than
patients with MS.36,37
Although a critical value of RNFL thickness has been pro-
posed, there was a considerable overlap in OCT measure-
ments between MS and NMO, limiting the role of OCT to
differentiate the two conditions on an individual basis.
Prognostic value and future developments of OCT in
MS
In addition to evaluate the damage (axonal and neuronal
loss) after each episode of ON and monitor the changes,
OCT may predict visual recovery.Costello et al. found a threshold of RNFL thickness (75 lm)
below which RNFL measurements predicted persistent visual
dysfunction with TD-OCT.23,24 More recently, they confirm
these findings using SD-OCT technology. Both one-month
RNFL and GCIPL values after ON predicted change in visual
field MD and VA at 6 and 12 months.38
In anterior optic neuritis, RNFL measurements obtained
closer to the acute episode can underestimate the amount
of true damage due to the swelling could mask the true
degree of RNFL loss (Fig. 5). Contrary to RNFL evaluation,
macular thickness and GCL changes are not influenced by
the optic nerve edema and could be more useful for detect-
ing the structural changes in the first month.39
Kupersmith observed in eyes suffering anterior ON, that at
1 month only 10% had RNFL loss, while near 70% of eyes had
GCL + IPL thinning.40 According to these data and in author’s
experience, CGL thinning can develop rapidly after ON, and
therefore it might be considered a biomarker of early struc-
tural loss.
The study of individual retinal layers opens up new per-
spectives in MS. Saidha et al. identified a subset of MS
patients with a unique pattern of retinal neuronal cell loss
(predominant macular thinning phenotype) in whom there
appears to be disproportionate thinning of the inner and
outer nuclear layers with relative sparing of the GCL and
more rapid disability progression.41 These findings support
the possibility of primary retinal pathology may be a harbin-
ger of a more aggressive form of MS.
OCT has been included in the most recent MS clinical trials,
and now is considered essential for assessing non-invasively
effectiveness of therapies that reduce axonal and neuronal
loss by neuroprotective or myelin repair mechanisms. A
combination of RNFL plus individual layers in the macula
may give the most complete picture of disease activity in
MS and ON, for study and therapeutic purposes focused on
axonal loss, neuronal degeneration or both. Moreover, clinical
trials have benefited from the presence of OCT reading
centers where certified technicians and prompt transmission
of data for ongoing quality control monitoring provide higher
data quality.
Figure 5. Left anterior optic neuritis. Ganglion cell layer thinning occurred as early as at 2 weeks after the acute episode, when optic disk swelling
masked the RNFL damage. One month later, once edema has resolved, both axonal and neuronal damage can be quantified. Hence, the presence of
GCL damage during optic disk edema has a striking prognostic value.
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the future include OCT angiography, polarization-sensitive
OCT (PS-OCT), and fluorescence labeling.4
There is some evidence that vascular co-morbidity is a
poor prognostic sign in MS. Swept-Source OCT angiography
that provides flow index measurements could be suitable for
evaluating optic nerve head and parafoveal perfusion in MS
patients.4,42
PS-OCT yields information about any light polarization
changing related to tissue birefringence. The birefringence
of the RNFL is related to the structure of neurofilaments
and microtubules and is not constant. Because of changes
the axonal cytoskeleton can precede axonal loss, PS-OCT
might be an opportunity to detect early stages of axonal
pathology in MS.43
Ischemic optic neuropathy
As in anterior ON, OCT measures optic disk edema and
monitors RNFL loss over time in patients with anterior ische-
mic optic neuropathy (AION).
Morphological changes comprise severe swelling after
onset of AION, which rapidly turns into atrophy. Contreras
et al. reported that mean OCT-measured RNFL thickness
increased to 96.4% in the affected eye compared with the fel-
low eye at the onset of nonarteritic AION (NAION). Already
after 2 months, more than 80% of the patients showed a
RNFL thinning. Progressive RNFL thinning between month
2 and month 4 suggests ongoing atrophy, whereas a stable
morphologic end point is reached after month 6.44–46
In the acute phase of AION, optic disk and axonal swelling
prevents by RNFL thickening to detect axonal damage. As
previously commented in anterior ON, a useful alternative
approach is to analyze GCL. Kupersmith demonstrated that
at 1 month, only 10% eyes with NAION had RNFL loss, while
76% had GCIPL thinning.40 Therefore GCL thinning can bedetected prior to RNFL loss, and could be a biomarker of
early structural loss in AION (Fig. 6).
A cupping enlargement is a well-known characteristic of
AION caused by giant cell arteritis. Although milder, OCT
has also demonstrated an enlargement of cupping after
NAION (around 50% of eyes had a cup to disk ratio that
differed from that in the fellow eye by more than 0.1).47,48
It has been hypothesized that most of the VA loss after a
NAION episode depends on the severity of the damage to
the papillo-macular bundle (PMB).49 In fact, in eyes with
significantly lower VA, the RNFL thickness of the temporal
quadrant by Stratus-OCT was almost 40% lower than that
of the fellow eye. Moreover there is a significant correlation
between nasal macular thickness by Stratus-OCT and VA in
patients with AION.
Rebolleda et al. have found a significant correlation
between VA and both temporal and PMB RNFL thicknesses,
as well as with several GCL and macular measurements using
the newer SD-OCT (ongoing study).
OCT can identify different patterns of RNFL involvement
specific to different classic visual field (VF) defects in eyes
with NAION. Bellusci et al. reported that eyes with VF defect
confined to the inferior hemifield had RNFL involvement lim-
ited to the temporal, superior and nasal optic disk quadrants.
Diffuse RNFL damage involving all quadrants around the disk
was observed in eyes with diffuse VF loss and eyes with cen-
tral or centro-cecal scotoma revealed RNFL atrophy limited
to the superior and temporal sectors of the disk.51
Macula and GCL are also thinner in NAION eyes and show
stronger correlation with VF than RNFL parameters.45,52,53
With newer automated segmentation software thinning of
individual macula layers including RNFL, inner plexiform
and GCL can be detected (ongoing study).
Macular analysis by OCT can demonstrate subretinal fluid
in around 12% patients with NAION that may contribute to
some of the visual loss associated with this condition and
Figure 6. Left anterior ischemic optic neuropathy. Top row: One week after acute visual acuity loss. (A) Optic nerve swelling causes RNFL thickening that
prevent evaluating if there is or not associated axonal loss (B). However GCIPL analysis (C) shows an abnormal thinning that correlates with the inferior VF
defect (D). Bottom row: two months after the acute episode. Superior optic disk pallor (A), superior RNFL quadrant thinning (B) and GCIPL thinning
(C) with the corresponding inferior VF defect (D).
14 G. Rebolleda et al.could account for some of the visual improvement that can
follow after its resolution (Fig. 7).54
Controversy exists regarding the optic disk size in NAION.
Although subjects suffering NAION have lower cup to disk
ratios than does the normal population, nerve fiber crowding
does not mean necessarily a small optic disk. In fact, Contre-
ras et al. did not show any significant difference in optic diskFigure 7. Diffuse pRNFL thickening and macular subretinal fluid connected to
AION (A) that resolves 3 months later, leading to RNFL thickness loss in the ssize between patients with NAION and control subjects.47
New Bruch’s membrane opening (BMO) disk size analysis
could be useful in the future to assist in addressing this
unanswered question.
OCT technology is a reliable and objective tool to assess
new therapies arising in the future for this devastating
disorder.55peripapillary edema is showed by Cirrus-OCT during an acute episode of
uperior and inferior quadrants (B).
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OCT provides reliable and quantitative information on
optic disk edema and structural changes during the
resolution of optic nerve head swelling. For lower grades of
papilledema, pRNFL analysis is very useful as an adjunct
method to confirm and quantify the severity of disk swelling.
However, in moderate to severe papilledema (Frisén grade 3
or above), substantial thickening of the pRNFL (average
RNFL >200 lm) causes the software algorithm to fail in over
a third of the cases, yielding inaccurate values of RNFL
thickness.56,57
A significant improvement in the quantification of papille-
dema was realized by segmenting the total retinal thickness
(TRT) in the same peripapillary scan, since the inner and
outer borders of the retina are more readily defined by
automated software in the presence of moderate to severe
papilledema.
Newer automated software segmentation of the retinal
layers using a 3D graph-based approach has significantly
improved upon the accuracy of defining the thickness of
the retinal layers in papilledema, resulting in much fewer
algorithm failures (Fig. 8). This approach has been used to
segment the volume of the optic disk, which highly correlates
with the RNFL, TRT and Frisén grade of papilledema in
patients with raised intracranial pressure.58
All OCT parameters of optic nerve head swelling, such as
average pRFNL thickness, pTRT, and optic nerve head (ONH)
volume and height are correlated. Although the ONH volume
correlates the best with the grading of photos, it has a mod-
est correlation with cerebral spinal fluid opening pressure.57
Perimetric sensitivity losses tended to be greater in eyes
with more edema.56
Another purpose of OCT is to differentiate if visual loss
associated to papilledema is due to optic neuropathy or mac-
ulopathy to guide management decisions. If it is caused by
optic neuropathy, it requires more aggressive approach than
if it is due to a more benign, reversible macular abnormality
such as subfoveal fluid or choroidal folds. The main problem
using pRNFL analysis in the follow-up, is there is no way,
based on OCT alone, to determine when edema reduces
and RNFL thickness returns toward normal values, whether
it is due to clinical improvement or if it is due to axon loss.
Sometimes, when optic disk edema resolves, axonal damage
has already occurred but yet cannot be detected anatomi-
cally, explaining why RNFL measures do not always correlate
with VF loss.Figure 8. Optic disk swelling due to idiopathic intracranial hypertension Fr
provides 3D-images of ONH volume and height.The GCIPL analysis by OCT in the setting of papilledema
may be suitable for the early detection of neuron loss and
to identify patients needing more aggressive treatment.
The hypothesis is that thinning of the GCL-IPL reveals early
signs of progressive optic neuropathy in the presence of
papilledema.
In the NORDIC Idiopathic Intracranial Hypertension Treat-
ment Trial (IIHTT), that represents the largest prospectively
analyzed cohort of untreated patients with IIH, 7.3% of eyes
had macular GCL + IPL thinning at presentation.59 These eyes
had worse VA compared with eyes with GCL thickness equal
to or greater than normal, indicating structural neuronal loss
not apparent from RNFL measurements due to swelling.
Larger studies will confirm whether GCL thinning at baseline
is a risk factor for not improving or having a worse outcome.
In author´s experience, a normal GCL thickness during the
follow-up is a good prognosis signal for recovering (Fig. 9).
In NORDIC IIHTT, GCIPL thickening occurred in 10% of
eyes that was associated with thicker ONH volume, RNFL
and TRT, suggesting that the axonal stasis associated to
papilledema can also affect the axons immediately con-
nected to the retina ganglion cells.59
In a minority of eyes, pRNFL and macular thickness may be
subnormal despite optic disk swelling, implying a combina-
tion of swollen and thin or missing axons.
Other macular abnormalities have been discovered thanks
to OCT. Photoreceptor loss has been described by SD-OCT
and is associated with central/paracentral scotomas.60
Newer generation of OCT instruments with enhanced
depth penetration and longer wavelength light provide
greater resolution of deeper structures, such as Bruch’s
membrane. Peripapillary deformations of Bruch’s membrane
surrounding the neural canal due to a differential pressure
between the retrobulbar optic nerve and vitreous cavity
may be useful in the diagnosis and management of intracra-
nial hypertension (IHT). In papilledema the shape of peripap-
illary retinal pigment epithelium (p-RPE)/Bruch membrane
has an inverted U-shape compared to normals who exhibit
a V-shape pointing away from the vitreous. These changes
in the p-RPE-shape are dynamic and could reflect a decrease
in the intracranial pressure after lumbar puncture and
treatment.61,62
Another recent development in OCT that might help to
understand the pathogenesis of visual loss in papilledema
due to ischemia is phase contrast OCT. This technology
allows to visualize capillaries and to quantify flow within a
capillary bed.63isén stage grade 4. SD-OCT shows a significant pRNFL thickening and
Figure 9. GCL-IPL analysis provides information about optic neuropathy in the presence of papilledema. (A) Idiopathic intracranial hypertension (IIH)
with normal GCIPL thickness despite a significant RNFL thickening at presentation (top row). Full recovery after conservative treatment (bottom row). (B)
IIH with abnormal GCIPL thinning at presentation (top row). Resolution of edema occurred after lumbo-peritoneal derivation (bottom row) surgery but
RNFL, GCIPL and VF damage are present and are more severe in the eye with more edema at baseline (right eye).
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Both RNFL and macular GCIPL analysis reveal significant
thinning in eyes with ONHD. As drusen develop and become
superficial, the RNFL thickness decreases. There is an
association between OCT measurements, numbers of clini-
cally visible ONHD and VF defects.64–66The temporal quadrant is often undamaged, probably
reflecting the preservation of central visual acuity.
Deep and buried drusen often produce a RNFL thickening
that can mask the axonal damage, yielding a false negative
result. In fact, Rebolleda et al. found that in eyes with buried
ONHD the abnormality rate was significantly higher with
GCIPL compared to RNFL evaluation. In fact, 26% of the eyes
OCT update in neuro-ophthalmology 17with buried ONHD, had abnormal GCIPL exams but normal
RNFL thicknesses by Cirrus-OCT.67
Although further work is needed to properly establish the
role of GCIPL analysis in eyes with buried ONHD, it seems
that GCIPL analysis may be more useful for detecting early
damage in eyes with buried drusen than RNFL exam. Longer
follow-up will determine if those cases with abnormal GCIPL
examination will eventually develop RNFL thinning and VF
defects (Fig. 10).
When ONHD is located superficially, the diagnosis is rela-
tively easy and can be made with careful ophthalmoscopic
observation. However, distinguishing papilledema from
pseudopapilledema due to deep and buried drusen, can be
challenging and clinical observation may be equivocal, partic-
ularly when the degree of edema is not severe (i.e. Frisén
grade 1 or 2).
Several qualitative and quantitative OCT criteria have
been proposed to help differentiate both disorders. The
quantitative parameters have showed greater sensitivity
and specificity than the qualitative criteria.68,69
Qualitative criteria for papilledema include an elevated
optic nerve head with smooth internal contour and subretinal
hyporeflective space (SHYPS) with recumbent ‘‘lazy V’’ pat-
tern. However, ONHD displayed a ‘‘lumpy-bumpy’’ internal
optic nerve contour and a rapid decline in the SHYPS
thickness.
Quantitative comparisons include nasal RNFL and SHYPS
thickness. Recently, Kulkarni et al. found no difference in
RNFL thickness between buried ONHD and papilledema in
any of the 4 quadrants.70
Using SD-OCT, Lee et al. reported that ONHD is visualized
as a focal, hyperreflective, subretinal mass with a discrete
margin.71 The outer nuclear layer smoothly covered the
drusen, which led to a hyporeflective, boot-shaped area
adjacent to the drusen (Fig. 11).Figure 10. Pseudo-papilledema due to bilateral buried ONHD. A significant th
axonal loss. GCIPL analysis is a valuable tool in this setting demonstrating anLately, several studies have assessed the value of
enhanced depth imaging optical coherence tomography
(EDI-OCT) in diagnosing and evaluating ONHD. Deeper-
penetration OCT imaging demonstrated the internal charac-
teristics of optic disk drusen and their relationship with the
lamina cribrosa in vivo. OHND appear as ovoid regions of
lower reflectivity bordered by hyperreflective material. Both
the larger the drusen are and the more area of the optic canal
is occupied by drusen, the greater RNFL abnormalities are
associated (Fig. 11).72
The use of autofluorescence (a modality offered on OCT
instruments that use a blue scanning laser), or ultrasound
scanning are also useful to detect buried OHND. However,
EDI-OCT detects ONHD more often and evaluates their
shape and structure better than non-EDI OCT and ultrasound
B scan.73
Dominant optic atrophy
Contrary to glaucoma, in patients with Dominant Optic
Atrophy (DOA), RNFL analysis shows a significant temporal
preference of RNFL loss followed by the inferior quadrant
and a relative sparing of the nasal fibers with a symmetric
appearance (Fig. 12).74
There is a significant correlation between average RNFL
and GCIPL thickness and VA.75,76
The ONH analysis shows a significantly smaller optic disk
area and disk diameters, compared with controls suggesting
that patients with DOA are born with fewer optic nerve
axons.77
Recently, Barboni et al. studied 39 patients with DOA
taking into account the severity of visual loss and the OPA1
mutation type. They reported that the loss of macular retinal
ganglion cells (RGC) was the earliest pathological event.
Thus, mild cases showed significant macular RGC loss asickening is showing in RNFL analysis by OCT-Cirrus, preventing to detect
abnormal thinning in both eyes.
Figure 11. Buried optic nerve head drusen. (A) SD-OCT demonstrated the optic drusen as a focal mass with a reflectance similar to the plexiform layers
(yellow arrow). The outer plexiform layer and the retinal pigment epithelium diverge as they approach the drusen given a boot-shape area adjacent to
the drusen (yellow dotted line). (B) EDI-OCT along two vertical scans showing the typical ovoid areas of lower reflectivity (white arrows) bordered by
hyperreflective material and multiple hyperreflective bands. C. En-face imaging that allows to visualize 3D data in a fundus projection, showing several
optic nerve hyperreflective drusen along the layers of increasing depth.
Figure 12. Dominant optic neuropathy. Bilateral temporal pallor and optic disk cupping, with bilateral RNFL loss that predominates in temporal and
inferior quadrants. Macular thinning is more pronounced in the corresponding inner and outer nasal and inferior macular quadrants.
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Figure 13. 24-Year-old male with Leber optic neuropathy. Fundus examination reveals a bilateral temporal pallor of the optic disk. GCIPL analysis (B)
shows a bilateral severe thinning that is more striking than thinning yielded by RNFL analysis (A).
Figure 14. Bilateral and symmetric optic neuropathy due to vigabatrin. Bilateral supero-nasal RNFL thinning and peripheral VF constriction (60-4 and 24-
2 strategies are superimposed).
OCT update in neuro-ophthalmology 19opposed to substantial maintenance of RNFL thickness,
which is significantly decreased only in severe cases and in
late stages of the disease.50,78
A clear genotype/phenotype correlation is emerging.
RNFL thinning is more pronounced in patients with DOA
plus phenotypes that develop additional neuromuscular
features.79Leber optic neuropathy
On the basis of OCT data, Barboni et al. firstly reported
that RNFL is thicker than normal in the presymptomatic and
early disease states with earliest changes in the temporal
and inferior quadrants.80
Figure 15a. Bitemporal hemianopsia more pronounced in the superior hemifields showing a significant thinning in the inferonasal sectors of both eyes in
the GCL analysis (B). The pRNFL thinning does not correspond with the visual field defect as clear as the GCL does.
Figure 15b. Bitemporal hemianopsia. CGL thinning predominates in the heminasal retina (white arrows), but it extends beyond midline crossing to the
temporal hemifield in both eyes.
20 G. Rebolleda et al.The temporal fibers (PMB) are the first and most severely
affected. In the late period significant pRNFL thinning is pres-
ent in all sectors.
The late involvement of both superior and nasal quadrants
suggests a dynamic evolution of the acute stage that contin-
ues for 3 months and may represent a therapeutic window of
opportunity.80,81
In childhood-onset Leber optic neuropathy (LHON) (equal
or less than 10 years of age) a significant diffuse reduction
of RNFL has been demonstrated, whereas a significant
reduction of the temporal quadrant was present in the slowly
progressive and subclinical LHON cases.82In unaffected carriers, a thickening of the temporal fibers
has also been described. Unaffected males have a more
diffuse involvement than females.83
Recently Ramos et al.84 found that the ONH size is larger
in LHON carriers than in LHON-affected, suggesting a pro-
tective role for this anatomic trait. Such hypothesis is rein-
forced by the observation that, among the LHON-affected,
larger disks correlated with visual recovery and better visual
outcome. The findings may be relevant for prognosis.
GCIPL is also diffusely damaged in LHON. More studies
will provide information about if early changes are present
in carriers and in subacute or early LHNO cases (Fig. 13).
Figure 16. RNFL thickness before orbital decompression for thyroid orbitopathy can predict whether there will be or not visual function recovery after
surgery. (A) Patient with Graves orbitopathy showing a RNFL thickness normal despite moderate VF damage preoperatively. Full VF recovery occurred
after surgery. (B) Woman with thyroid orbitopathy had both VF and RNFL analysis damaged before surgery, so that no recovery happens after
decompressive surgery.
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Alzheimer’s disease (AD) is the most common cause of
dementia. A recent meta-analysis showed that in AD
patients, there was a significant RNFL thickness reduction
compared with healthy subjects.85,86 Controversy exists
about the correlation between RNFL measurements and
the severity of the dementia.87
In addition to RNFL thinning, choroid, macular and GCL
thickness are also reduced even without visual failure.87–89
Over the last few decades, earlier stages of AD have been
identified , which include mild cognitive impairment (MCI).
Early detection is necessary to identify cognitively normal
individuals who have a high risk of developing MCI and AD,
so that interventions can prevent or delay the progression.Recently, it has been suggested that the detection of the pla-
ques in the retina early in the disease, before the onset of
dementia or very early in the course of the disease, and
examination with fundus autofluorescence (FAF) and OCT is
extremely important and may be a valuable supplement to
neurological testing.90
More studies are necessary to assess whether choroidal,
RNFL o GCIPL thickness represent an adjunctive biomarker
for the diagnosis and follow-up of this pathology.
Parkinson’s disease
Parkinson’s disease (PD) is a neurodegenerative process
that leads to the selective loss of dopaminergic neurons,
mainly in the basal ganglia of the brain. Numerous studies
Figure 17. Right homonymous hemianopsia due to an intracranial hemorrhage in the left temporal lobe (shown in the CT scan). A significant GCL
thinning is shown in the projecting sector of the retina mapping to the brain lesion, so that the nasal hemiretina of the right eye and the temporal
hemiretina of the left eye (contra and ipsilateral to the brain lesion respectively).
22 G. Rebolleda et al.have analyzed the ability of OCT to detect abnormalities in
PD.91–96
Both RNFL and macular thickness are significantly reduced
in patients with PD and correlate with PD severity.95,96
SD-OCT is a valid and reproducible device for detecting
subclinical RNFL atrophy in patients with PD, especially the
Nsite Axonal Analysis of the Spectralis OCT device. Further-
more, the newer segmentation algorithm of the Spectralis
OCT revealed retinal layer atrophy especially in the inner lay-
ers of patients with longer disease duration.96
Spund et al. reported that the foveal pit is thinner and
broader in PD.97 This remodeling of the foveal architecture
raises a novel concept and may represent a visible and quan-
tifiable signature of PD.
Although OCT is a promising quantitative tool in PD
research, larger studies are needed before applying it to clin-
ical follow-up.Other optic neuropathies
OCT can be useful in many other optic neuropathies, for
instance to detect early damage in case of retrobulbar origin
optic atrophy.
In traumatic optic neuropathy, OCT can reveal RNFL loss
from 2 week to 4 weeks after trauma.
In toxic/nutritional-induced optic neuropathies, RNFL
thickness may be normal or slightly increased on initial evalu-
ation and become thinned, especially temporally, on future
testing.98 The observed thinning of the temporal RNFL corre-
sponds to the more significant effects on the papillo-macular
fibers.Contrary to the predominant temporal RNFL thinning pat-
tern of toxic neuropathies, a recognizable and characteristic
form of peripheral retinal atrophy and nasal or ‘‘inverse’’
RNFL loss can occur in children being treated with vigabatrin
(Fig. 14).99,100
OCT-measured RNFL and GCL are also thinned in com-
pressive optic neuropathy regardless of its etiology.
In optic chiasm syndrome, OCT could quantitatively
detect the band atrophy (BA) of the optic disk. The relatively
preserved superior and inferior RNFL bundles correlated with
the findings of bitemporal hemianopsia.94,95 Both macular
and GCL analyses are more useful to detect BA than RNFL
analysis (Fig. 15a).96,101,102 Eyes with BA of the optic nerve
show significant thinning of the retinal GCL thickness on
the nasal macular area, but in author´s experience is not
uncommon to find a more extended area of GCL thinning
compared to VF loss (Fig. 15b).
Besides its diagnosis value, in chiasmal tumors, OCT has a
predictive role so that the degree of reversibility is related to
the preoperative RNFL thickness.103 Patients who have objec-
tively measurable RNFL loss at the time of surgery for chias-
mal compressive lesions are less likely to return of VA or VF
after surgery. We have observed similar findings in patients
following orbital decompression for thyroid eye disease and
associated optic neuropathy (Fig. 16).
Controversy remains regarding the occurrence of optic
nerve degeneration following post-geniculate hemianopsia.
Retrograde transsynaptic degeneration of retinal ganglion
cell layer (GCL) has been proposed as one of the mechanisms
contributing to permanent disability after visual pathway
damage104,105 (Fig. 17). Recently, Keller et al. have reported
a significant thinning of the GCL in patients with a
OCT update in neuro-ophthalmology 23retrogeniculate lesion.105 The correlation between VF defect
and GCL thickness was stronger than that observed between
VF and pRNFL, probably because at the macula the neuron
bodies are topographically organized to correspond to the
VF.
These findings provide new insights regarding transsynap-
tic degeneration of the visual system, supporting the use of
GCL thickness as in imaging marker after brain lesions.Emerging applications and future direction of OCT
Advancements in OCT technology continue to evolve at a
quick step. The acquisition of scans is much faster in swept
source OCT (SS-OCT) when compared with the SD-OCT
and it is very useful for adequate analysis of choroidal thick-
ness and volume in healthy and diseased states.
The commercialization of mobile SD-OCT systems may
expand the application spectrum to analyze subjects mani-
festing significant deteriorated motion, including adult and
pediatric patients groups. In fact, hand-held OCT (HH-OCT)
has already been used to quantify pRNFL thickness in chil-
dren with optic pathway gliomas showing a close relationship
to visual function.
New emerging functional SD-OCT imaging modalities
such as Doppler-SD for blood-flow Imaging and Polariza-
tion-Sensitive OCT had a wide spectrum of potential diag-
nostic applications.
As advanced super-luminescent diodes and femtolaser
technologies have become cheaper, commercial ultra-high
Resolution OCT machines (approximating 2–3 lm of resolu-
tion) will emerge as options to consider.106
OCT technology is changing very quickly and throughout
this review there are only some of the multiple possibilities
that will emerge in the next future in the field of Neuro-
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